Skip to content

Clinical trials

Recruiting Schizophrenia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Recruiting Country / region: China Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20161
20211
20221
20233
202410
20257
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Mental Health Center9
Central South University7
Anhui Medical University1
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.1
Capital Medical University1
Chunyan Zhu1
Eli Lilly and Company1
Luye Pharma Group Ltd.1
Peking University1
Ruijin Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia32
Bipolar Disorder6
Mental Disorders4
Psychotic Disorders3
Autism Spectrum Disorder2
Major Depressive Disorder2
Anorexia Nervosa1
Autistic Disorder1
Body Weight1
Cognitive Dysfunction1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.